Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Pharmacokinetic properties and metabolism of idebenone.
Treatment with 4-aminopyridine improves upper limb tremor of a patient with multiple sclerosis: a video case report.
Brain reserve and cognitive reserve in multiple sclerosis: What you've got and how you use it.
Mountain View Pharmaceuticals receives European patent on potential long-acting drug for multiple sclerosis
Ofatumumab
Vitamin D and multiple sclerosis: epidemiology, immunology, and genetics.
Intellectual enrichment lessens the effect of brain atrophy on learning and memory in multiple sclerosis.
The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-α
No evidence for higher risk of cancer in patients with multiple sclerosis taking cladribine.
Amiloride: a molecular probe of sodium transport in tissues and cells.
Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis
Specific peripheral B cell tolerance defects in patients with multiple sclerosis.
Balance impairment in people with multiple sclerosis: Preliminary evidence for the Balance Evaluation Systems Test.
Reduction in healthcare and societal resource utilization associated with cladribine tablets in patients with relapsing-remitting multiple sclerosis: analysis of economic data from the CLARITY Study.
Testing effects of glatiramer acetate and fingolimod in an infectious model of CNS immune surveillance.
Pathway and network-based analysis of genome-wide association studies in multiple sclerosis.
Pathological mechanisms in progressive multiple sclerosis.
CD56(bright) natural killer cells and response to daclizumab HYP in relapsing-remitting MS.
Reactive astrocytes as therapeutic targets for CNS disorders.
Oral treatment with laquinimod augments regulatory T-cells and brain-derived neurotrophic factor expression and reduces injury in the CNS of mice with experimental autoimmune encephalomyelitis.
A promising therapeutic approach for treatment of posterior uveitis: recombinant T cell receptor ligand protects Lewis rats from acute and recurrent experimental autoimmune uveitis.
Monomethyl fumarate promotes Nrf2-dependent neuroprotection in retinal ischemia-reperfusion.
Genzyme's Lemtrada resubmission accepted for review by FDA
Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosis.
Idebenone for primary progressive multiple sclerosis

Pages